We are live on ! Find out more
SFM

Sphera Funds Management Portfolio holdings

AUM $630M
1-Year Est. Return 108.65%
This Fund
S&P 500
This Quarter Est. Return
+6.31%
1 Year Est. Return
+108.65%
3 Year Est. Return
+217.64%
5 Year Est. Return
+342.91%
10 Year Est. Return
+2,254.45%
AUM
$852M
AUM Growth
+$151M
Cap. Flow
+$154M
Cap. Flow %
18.03%
Top 10 Hldgs %
46.73%
Holding
164
New
33
Increased
26
Reduced
31
Closed
28

Top Buys

Rank Stock Value
1
VTRS icon
Viatris
VTRS
+$28.9M
2
ALXN
Alexion Pharmaceuticals
ALXN
+$14.6M
3
VRTX icon
Vertex Pharmaceuticals
VRTX
+$9.62M
4
FOLD
Amicus Therapeutics
FOLD
+$9.34M
5
PRTA icon
Prothena Corp
PRTA
+$7.38M

Top Sells

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$18.6M
2
BIIB icon
Biogen
BIIB
+$9.88M
3
ITRN icon
Ituran Location and Control
ITRN
+$8.27M
4
ORBK
Orbotech Ltd
ORBK
+$6.41M
5
ZGNX
Zogenix, Inc.
ZGNX
+$5.08M

Sector Composition

Rank Sector Weight
1 Healthcare 58.93%
2 Technology 3.62%
3 Communication Services 2.25%
4 Financials 1.01%
5 Consumer Discretionary 0.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LOW icon
126
Lowe's Companies
LOW
$117B
$242K 0.03%
2,600
– –
SEE
127
DELISTED
Sealed Air
SEE
$222K 0.03%
4,500
– –
ULTI
128
DELISTED
Ultimate Software Group Inc
ULTI
$175K 0.02%
800
– –
XRAY icon
129
Dentsply Sirona
XRAY
$2.68B
$165K 0.02%
2,500
– –
LVNTA
130
DELISTED
Liberty Interactive Corporation Series A Liberty Ventures
LVNTA
$163K 0.02%
3,000
– –
TRIP icon
131
TripAdvisor
TRIP
$1.65B
$138K 0.02%
4,000
– –
CMG icon
132
Chipotle Mexican Grill
CMG
$47.2B
$116K 0.01%
20,000
– –
VSTO
133
DELISTED
Vista Outdoor Inc.
VSTO
$87K 0.01%
6,000
– –
CDTX
134
DELISTED
Cidara Therapeutics
CDTX
$5K ﹤0.01%
+40
New +$6.07K
ATHX
135
DELISTED
Athersys, Inc. Common Stock
ATHX
$1K ﹤0.01%
31
– –
CSTE icon
136
Caesarstone
CSTE
$72.3M
– –
-17,833
Closed -$531K
CYTK icon
137
CALL
Cytokinetics
CYTK
$10.5B
– –
-100,000
Closed -$1.45M
GILD icon
138
Gilead Sciences
GILD
$162B
– –
-230,000
Closed -$18.6M
GLD icon
139
SPDR Gold Trust
GLD
$131B
– –
-33,190
Closed -$4.04M
INSM icon
140
Insmed
INSM
$21.4B
– –
-135,000
Closed -$4.21M
ITRN icon
141
Ituran Location and Control
ITRN
$1.09B
– –
-229,283
Closed -$8.27M
KRNT icon
142
Kornit Digital
KRNT
$705M
– –
-67,006
Closed -$1.02M
NCNA
143
NuCana
NCNA
$5.49M
– –
-10
Closed -$919K
ORCL icon
144
Oracle
ORCL
$374B
– –
-47,250
Closed -$2.29M
ORLY icon
145
CALL
O'Reilly Automotive
ORLY
$72.9B
– –
-150,000
Closed -$2.15M
SEDG icon
146
SolarEdge
SEDG
$2.51B
– –
-102,003
Closed -$2.91M
SPNS
147
DELISTED
Sapiens International
SPNS
– –
-354,866
Closed -$4.65M
SRPT icon
148
CALL
Sarepta Therapeutics
SRPT
$1.57B
– –
-150,000
Closed -$6.8M
TEVA icon
149
PUT
Teva Pharmaceuticals
TEVA
$40.8B
– –
-72,000
Closed -$1.27M
TVTX icon
150
Travere Therapeutics
TVTX
$5.2B
– –
-174,131
Closed -$4.33M
3 4 5
6
7

Similar funds

VIM
Vancity Investment Management Vancouver, British Columbia, Canada $629M AUM 2.49% 1-Year Est. Return
KCMH
Keywise Capital Management (HK) Hong Kong $630M AUM 81.01% 1-Year Est. Return
FCFC
First Commonwealth Financial Corp Indiana, Pennsylvania $629M AUM 20.47% 1-Year Est. Return
BI
BlueSpruce Investments Chicago, Illinois $631M AUM 11.83% 1-Year Est. Return
PWW
Pettyjohn Wood & White Lynchburg, Virginia $628M AUM 20.96% 1-Year Est. Return
TTSTC
Texas Treasury Safekeeping Trust Company Austin, Texas $628M AUM 15.58% 1-Year Est. Return
SWP
Summit Wealth Partners Orlando, Florida $632M AUM 9.71% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return

Sphera Funds Management's Q4 2017 Portfolio in Review

As of Q4 2017, Sphera Funds Management held 164 positions worth $852M, up 22% from $701M the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Sphera Funds Management deployed $154M of net new capital in Q4 2017, opening 33 new positions and adding to 26 existing holdings. Its largest new stake was Viatris: 756,449 shares worth $32M.

By sector, the portfolio is most concentrated in Healthcare at 59% of assets, down from 63% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was Biogen, an estimated $9.88M trimmed.

  • Sphera Funds Management's largest Q4 2017 buy was Viatris: 756,449 shares worth $32M.
  • Sphera Funds Management added most to Vertex Pharmaceuticals in Q4 2017, an estimated $9.62M increase.
  • Sphera Funds Management's biggest Q4 2017 reduction was Biogen, cutting an estimated $9.88M.
  • Sphera Funds Management fully exited Gilead Sciences in Q4 2017, selling an estimated $18.6M.
  • Sphera Funds Management's ten largest holdings make up 47% of its $852M portfolio in Q4 2017.
  • Sphera Funds Management opened 33 new positions and closed 28 in Q4 2017.
  • Sphera Funds Management's portfolio value rose 22% quarter-over-quarter to $852M.

Based on Sphera Funds Management's 13F filing for Q4 2017, filed 12 Feb 2018.